Establishment Labs

About:

Establishment Labs, the next generation breast aesthetics company,

Website: http://establishmentlabs.com/

Top Investors: Perceptive Advisors, RTW Investments, Nantahala Capital Management, Oaktree Capital Management, Madryn Asset Management

Description:

Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to the strictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.

Total Funding Amount:

$581M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

New York, New York, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)motivaimplants.com

Founders:

Juan José

Number of Employees:

501-1000

Last Funding Date:

2024-11-07

IPO Status:

Public

© 2025 bioDAO.ai